This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 29 Dec 2017  |  North America  |  Technology Research

    Innovations in Transdermal Drug Delivery

    Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry

    With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

    $4,950.00
  2. 20 Dec 2017  |  North America  |  Market Research

    Strategic Insight into the Global Women’s Healthcare Market, 2017

    Opportunities in Point-of-care (POC) Diagnostics for Cardiology and Oncology, along with Wearables, Stand out in the Market

    Across the world, women typically live longer than men. The reason behind the difference between male and female life expectancy is unclear but could be explained through biological, environmental, and behavioral factors. Because women typically outlive men, they are more likely to suffer from ill health and other age-related diseases. Women’s he...

    $1,500.00
  3. 12 Dec 2017  |  North America  |  Market Research

    Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

    Digitalization in Drug Discovery Presents Significant Growth Opportunities for Healthcare IT Companies

    The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutio...

    $1,500.00
  4. 27 Nov 2017  |  North America  |  Mega Trends

    Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

    New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

    Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

    $4,950.00
  5. 07 Nov 2017  |  North America  |  Market Research

    Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

    Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success

    The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...

    $1,500.00
  6. 31 Oct 2017  |  North America  |  Market Research

    Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

    A Disruptive Technology—Gene-editing Tools for Multiple Applied Industries

    Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in fun...

    $3,000.00
  7. 17 Jul 2017  |  North America  |  Market Research

    US Oncology Diagnostics Market, Forecast to 2021

    Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

    Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consoli...

    $4,950.00
  8. 30 Jun 2017  |  Europe  |  Mega Trends

    Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

    Data-driven Solutions and Co-development are Key Growth Drivers

    The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...

    $4,950.00
  9. 23 Jun 2017  |  Europe  |  Market Research

    Growth Opportunities in the Western European IVD Industry, Forecast to 2021

    Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

    Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...

    $4,950.00
  10. 20 Jun 2017  |  North America  |  Market Research

    Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market

    Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth

    Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...

    $4,950.00